Inventor · disambiguated record
Suezanne Parker
Also filed as: PARKER SUEZANNE · PARKER SUEZANNE E
6 granted patents·5 pending applications·409 citations·filing 1994–2024
87Inventor score
Top patents by PatentIndex Score
11 records- 0196US7268120B1Methods for treating cancer using cytokine-expressing polynucleotidesVICAL INC·Filed 2000·Granted Sep 11, 2007·127 cites·37 claims
- 0294US6147055ACancer treatment method utilizing plasmids suitable for IL-2 expressionVICAL INC·Filed 1997·Granted Nov 14, 2000·167 cites·24 claims
- 0391US6399588B1Cancer treatment method utilizing plasmids suitable for IL-2 expressionVICAL INC·Filed 2000·Granted Jun 4, 2002·40 cites·51 claims
- 0489US5641665APlasmids suitable for IL-2 expressionVICAL INC·Filed 1994·Granted Jun 24, 1997·66 cites·9 claims
- 0585US7470675B2Methods for treating cancer using interferon-ω-expressing polynucleotidesVICAL INC·Filed 2007·Granted Dec 30, 2008·9 cites·30 claims
- 0673US2025136953A1Compositions and methods for the treatment of ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0765US12351834B2Compositions and methods for the treatment of ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2021·Granted Jul 8, 2025·0 cites·37 claims
- 0865US2005065107A1Plasmids suitable for IL-2 expressionFiled 2004·Application pending·0 cites
- 0957US2003203863A1Plasmids suitable for IL-2 expressionVICAL INC·Filed 2002·Application pending·0 cites
- 1045US2004087521A1Nucleic acid pharmaceuticals-influenza matrixMERCK & CO INC·Filed 2001·Application pending·0 cites
- 1139US2003091544A1Interferon-Beta polynucleotide therapy for autoimmune and inflammatory diseasesVICAL INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Suezanne Parker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →